Subconjunctival autologous platelet-rich plasma as an adjunctive therapy for limbal-scleral ischemia following acute ocular burns: a prospective randomized pilot trial.

Atighehchian M, Ghassemi H, Zarei-Ghanavati S, Latifi G, Zarei-Ghanavati M

Open source

DOI
10.1186/s12886-026-05225-6
Published
2026 Aug 17
Container
BMC ophthalmology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12886-026-05225-6,
  title = {Subconjunctival autologous platelet-rich plasma as an adjunctive therapy for limbal-scleral ischemia following acute ocular burns: a prospective randomized pilot trial.},
  author = {Atighehchian M and Ghassemi H and Zarei-Ghanavati S and Latifi G and Zarei-Ghanavati M},
  year = {2026},
  journal = {BMC ophthalmology},
  doi = {10.1186/s12886-026-05225-6},
  url = {https://doi.org/10.1186/s12886-026-05225-6}
}

RIS

TY  - JOUR
TI  - Subconjunctival autologous platelet-rich plasma as an adjunctive therapy for limbal-scleral ischemia following acute ocular burns: a prospective randomized pilot trial.
AU  - Atighehchian M
AU  - Ghassemi H
AU  - Zarei-Ghanavati S
AU  - Latifi G
AU  - Zarei-Ghanavati M
PY  - 2026
JO  - BMC ophthalmology
DO  - 10.1186/s12886-026-05225-6
UR  - https://doi.org/10.1186/s12886-026-05225-6
ER  - 

APA

M, A., H, G., S, Z., G, L., & M, Z. (2026). Subconjunctival autologous platelet-rich plasma as an adjunctive therapy for limbal-scleral ischemia following acute ocular burns: a prospective randomized pilot trial.. BMC ophthalmology. https://doi.org/10.1186/s12886-026-05225-6

Source records